小智港股覆盤 | 11月11日
今日,港股三大指數集體上漲。截止收盤,恆生指數漲1.01%,報25247點。國企指數漲1.54%,報9048點。恆生科技指數漲1.8%,報6464點。市場約1090只個股上漲,608只個股下跌。成交額突破1363.44億港幣,和昨天同期相比增長0.07%。南下資金淨流出28.03億港幣。

盤面上,綜合消費服務板塊全線走強。希望教育漲超22%;新東方在線漲超14%;嘉宏教育漲超12%;東京中央拍賣漲超11%;中彙集團漲超10%。希望教育回彈近20%,併購紅利釋放,新學年招生數大幅增加;東京中央拍賣盈喜:預計中期純利1160萬港元,同比扭虧。

消費品板塊表現強勁。創維集團漲超11%;蜆殼電業漲超9%;興利(香港)控股漲超7%;敏華控股、裕興科技等多股漲超6%。創維集團回購190.4萬股,涉資851.13萬元;花旗下調敏華目標價至19元,評級「買入」;裕興科技前三季度股東應佔虧損1900萬港元,同比減少29.16%。

化學制品板塊集體拉昇。華寶國際漲超9%;中國三江化工漲超6%;中國旭陽集團、世紀陽光等多股漲超5%;綠新親水膠體漲超4%。華寶國際:集團成員公司已認購興業銀行11億元金融產品;中國旭陽集團獲執行董事楊路增持10萬股。

生物科技板塊走低。君實生物、康方生物-B等多股跌超7%;信達生物跌超6%;百濟神州跌超5%;康寧傑瑞製藥-B跌超3%。君實生物午後急升9%,PD-1整體降幅料可控;康方生物-B擬回購最多1億港元股份;中金:醫藥股已具備配置價值,看好藥明生物、信達生物等;百濟神州午後拉昇近6%,前九月總收入同比增長360.93%至9.62億美元;興業證券:維持康寧傑瑞製藥-B“買入”評級,目標價27.15港元。

uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.